Hasil Pencarian - Tengteng Yu

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Experimental Study of CO2-Water-Mineral Interactions and Their Influence on the Permeability of Coking Coal and Implications for CO2-ECBM

    Experimental Study of CO2-Water-Mineral Interactions and Their Influence on the Permeability of Coking Coal and Implications for CO2-ECBM oleh Hui Guo, Xiaoming Ni, Yanbin Wang, Xiaomin Du, Tengteng Yu, Ruimin Feng

    Diterbitkan 2018-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma

    Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma oleh Shih-Feng Cho, Liang Lin, Lijie Xing, Tengteng Yu, Kenneth Wen, Kenneth C. Anderson, Yu-Tzu Tai

    Diterbitkan 2017-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells

    Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells oleh Shaowei Qiu, Shuang Liu, Tengteng Yu, Jing Yu, Min Wang, Qing Rao, Haiyan Xing, Kejing Tang, Yinchang Mi, Jianxiang Wang

    Diterbitkan 2017-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma

    Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma oleh Jian Cui, Rui Lv, Tengteng Yu, Wenqiang Yan, Jingyu Xu, Huishou Fan, Lingna Li, Yuntong Liu, Chenxing Du, Shuhui Deng, Weiwei Sui, Yan Xu, Shuhua Yi, Dehui Zou, Lugui Qiu, Gang An

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

    γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation oleh Hailin Chen, Tengteng Yu, Liang Lin, Lijie Xing, Shih-Feng Cho, Kenneth Wen, Kimberly Aardalen, Adwait Oka, Joni Lam, Mike Daley, Haihui Lu, Nikhil Munshi, Kenneth C. Anderson, Yu-Tzu Tai

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Longitudinal genetically detectable minimal residual disease by fluorescence hybridization confers a poor prognosis in myeloma

    Longitudinal genetically detectable minimal residual disease by fluorescence hybridization confers a poor prognosis in myeloma oleh Jian Cui, Tengteng Yu, Rui Lv, Jiahui Liu, Huishou Fan, Wenqiang Yan, Jingyu Xu, Chenxing Du, Shuhui Deng, Weiwei Sui, Matthew Ho, Yan Xu, Kenneth C. Anderson, Xifeng Dong, Lugui Qiu, Gang An

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma

    Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma oleh Zhen Yu, Xiaojing Wei, Lanting Liu, Hao Sun, Teng Fang, Lu Wang, Ying Li, Weiwei Sui, Kefei Wang, Yi He, Yaozhong Zhao, Wenyang Huang, Gang An, Fancui Meng, Changjiang Huang, Tengteng Yu, Kenneth C. Anderson, Tao Cheng, Lugui Qiu, Mu Hao

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: